Balhara Yatan Pal Singh, Parmar Arpit, Sarkar Siddharth
Department of Psychiatry and National Drug Dependence Treatment Centre, All India Institute of Medical Sciences, New Delhi, India.
J Neurosci Rural Pract. 2018 Jul-Sep;9(3):397-403. doi: 10.4103/jnrp.jnrp_42_18.
Opioids are one of the most common illicit psychoactive substances being used in India. In fact, opioid use disorders are the most common disorder presenting to the substance use disorder treatment centers across the country. Effective and evidence-based interventions are available for management of opioid use disorders. However, the treatment for opioid use disorders remains difficult to access for most of those in need in India. The current article presents the literature on the use of tramadol for the management of opioid use disorders. It also makes recommendations on the use of tramadol for the management of opioid use disorders. Tramadol offers a viable alternative to the existing options for the management of opioid use disorders. It has been found effective when used for this indication. It offers certain major advantages such as easy and wide availability and low abuse liability. It offers a good option to expand the treatment services for opioid use disorders across the country.
阿片类药物是印度最常用的非法精神活性物质之一。事实上，阿片类药物使用障碍是全国物质使用障碍治疗中心最常见的疾病。有有效的循证干预措施可用于管理阿片类药物使用障碍。然而，在印度，大多数有需要的人仍难以获得阿片类药物使用障碍的治疗。本文介绍了关于曲马多用于管理阿片类药物使用障碍的文献。它还就曲马多用于管理阿片类药物使用障碍提出了建议。曲马多为现有的阿片类药物使用障碍管理方案提供了一个可行的替代选择。已发现其用于该适应症时有效。它具有一些主要优点，如易于广泛获取且滥用可能性低。它为在全国范围内扩大阿片类药物使用障碍的治疗服务提供了一个好的选择。
